Immunotech Laboratories Corporate Shareholder Update Summary
5/9/2013 9:27:27 AM
More...
|
Immunotech Laboratories Provides Funding Update
4/29/2013 11:26:50 AM
More...
|
Immunotech Laboratories Begins Regulatory Process With FDA
4/26/2013 9:48:47 AM
More...
|
Immunotech Laboratories Appoints New VP of Business Development
4/15/2013 9:28:57 AM
More...
|
Immunotech Laboratories Retains The Lebrecht Group to Upgrade the Company to Fully Reporting Status
4/8/2013 9:35:10 AM
More...
|
Immunotech Laboratories in Discussions for Pre-"IND" Testing of Aids-HIV "IPF" Treatment in the USA
3/18/2013 9:29:40 AM
More...
|
Immunotech Laboratories Founder & Chief Scientific Officer Harry Zhabilov Comments on Recent HIV Baby Cure Medicine
3/12/2013 9:04:34 AM
More...
|
Immunotech Laboratories Announces Canadian Special Access Program Could Allow Legal Treatment of Company's Patented (IPF-ITV-1) AIDS-HIV Treatment
3/7/2013 9:41:55 AM
More...
|
Immunotech Laboratories Relocates to New Research & Development Laboratory Facility
3/1/2013 9:29:12 AM
More...
|
Immunotech Laboratories Announces Clinical Trials Updates for Company's AIDS-HIV "IPF" Medicines
2/21/2013 9:16:22 AM
More...
|
|